Federal Ministry of Research, Technology and Space · Almanya

KMU-innovativ: Medical technology (BMFTR)

Açık

Başvurular 15 Nisan 2027 tarihinde kapanıyor.

Son başvuru: 15 Nisan 2027 (151 gün kaldı)
Hibe tutarı: Başvuru sahibi başına en fazla €300.000
Destek oranı: De-minimis route: up to 80% for micro and small companies, up to 70% for medium-sized (max. €300,000); otherwise GBER rates with SME bonuses
Olası başvuru sahipleri: KOBİ’ler / girişimler, Şirketler Kaynak kategorilerinden veya program kurallarından; uygunluğa çağrı karar verir.
Fon sağlayıcı: Federal Ministry of Research, Technology and Space (BMFTR)
Referans: KMU-innovativ: Medizintechnik
Son kontrol: 15 Kasım 2026

Resmi çağrıyı aç ↗ Son tarihi takvime ekle

Program özeti

High-risk research and pre-competitive development of innovative medical devices, in-vitro diagnostics and digital medical technologies, run by SMEs together with research, clinical and healthcare partners.

Kimler başvurabilir

SMEs, typically in collaborative projects with research institutions, clinical partners and healthcare organisations; in collaborative projects at least 50% of the requested funding must go to the participating SMEs. Results may only be exploited in Germany, the EEA or Switzerland.

Başvuru sahibi kategorileri yalnızca bir başlangıç noktasıdır. Uygunluğa resmi çağrı karar verir.

Zamanlama

Project outlines are due on 15 April and 15 October each year (next: 15 April 2027); late outlines may move to the next date.

Nasıl başvurulur

Check the project fits the guideline (medical devices, IVD or digital medical technology; companion diagnostics belong to KMU-innovativ: Biomedizin).
Form the collaboration of SMEs with research, clinical or healthcare partners.
Prepare the project outline in easy-Online (https://foerderportal.bund.de/easyonline) for the next cut-off; formal applications follow only on invitation.
Read the amendment of 20 October 2026 and contact the project management agency named there.

✓ Checked against the official call text on 2026-11-15 (BMFTR announcement KMU-innovativ: Medizintechnik (BAnz 06.02.2026) and amendment (BAnz 20.10.2026)).

From the call text

Who can apply: SMEs as defined by the EU, and mid-sized companies under the national rule (up to 1,000 employees, as defined in the guideline), working with research institutions, clinical partners and healthcare organisations.
Company stage: High-risk research and pre-competitive development of medical devices, in-vitro diagnostics or digital medical products (risk class I/A only if highly innovative).
Single applicant or consortium: Collaborative projects of SMEs with research, clinical and healthcare partners.
Where applicants must be based: As stated in the guideline.
Where to apply: Project outlines and formal applications through the federal easy-Online system (foerderportal.bund.de/easyonline); the project management agency named in the announcement handles questions.

Resmi kaynaklar

Resmi çağrı sayfası · Latest official notice: Änderung: KMU-innovativ: Medizintechnik

Bu sayfadaki bilgiler resmi kaynaktan alınmıştır ve en son 15 Kasım 2026 tarihinde kontrol edilmiştir. Sonraki değişiklikler dahil, fon sağlayıcının kendi belgeleri her zaman önceliklidir.